The effects of neuromuscular facilitation techniques on osteoporosis of hemiplegia limbs and serum leptin level in patients or rats with cerebral infarction

References

• Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. The Lancet Neurology 2009;8:345–354.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Measuring the global burden of disease. The New England Journal of Medicine 2013;369:448–457.
   PubMed Web of Science ®Google Scholar
• Fang XH, Wang CX, Mei L-P, Liu M, Ji XM, Li LM. Progress in epidemiology study on stroke. Chinese Journal of Epidemiology 2011;32:847–857.
   Google Scholar
• Yoshimura N, Suzuki T, Hosoi T, Orimo H. Epidemiology of hip fracture in Japan: incidence and risk factors. Journal of Bone and Mineral Metabolism 2005;23 (Suppl):78–80.
   PubMed Web of Science ®Google Scholar
• Dai L, Chen Q, Wang T. The clinical application of neuromuscular facilitation techniques in the hemiplegic rehabilitation of the upper limb. Chinese Journal of Rehaiblitation Medicine 2005;19:827–829.
   Google Scholar
• Desai BN, Harris RB. Leptin in the hindbrain facilitates phosphorylation of STAT3 in the hypothalamus. American Journal of Physiology Endocrinology and Metabolism 2015;308:E351–361.
   PubMed Web of Science ®Google Scholar
• Zhang P, Zhong ZH, Yu HT, Liu B. Significance of increased leptin expression in osteoarthritis patients. PLoS One 2015;10:e0123224.
   Google Scholar
• Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke;A Journal of Cerebral Circulation 1989;20:84–91.
   PubMed Web of Science ®Google Scholar
• Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Archives of Internal Medicine 2004;164:1108–1112.
   PubMed Web of Science ®Google Scholar
• Bainbridge NJ, Davie MW, Haddaway MJ. Bone loss after stroke over 52 weeks at os calcis: influence of sex, mobility and relation to bone density at other sites. Age and Ageing 2006;35:127–132.
   PubMed Web of Science ®Google Scholar
• Davey RA, Morris HA. Effects of estradiol and dihydrotestosterone on osteoblast gene expression in osteopenic ovariectomized rats. Endocrine Research 2004;30:361–368.
   Google Scholar
• Gad HI. The potential osteogenic effects of systemic leptin and insulin administration in streptozotocin-induced diabetic female rats. Saudi Medical Journal 2007;28:1185–1190.
   PubMed Web of Science ®Google Scholar
• Kang KY, Hong YS, Park SH, Ju JH. Increased serum alkaline phosphatase levels correlate with high disease activity and low bone mineral density in patients with axial spondyloarthritis. Seminars in Arthritis and Rheumatism 2015;45:202–207.
   PubMed Web of Science ®Google Scholar
• Zhao D, Wang J, Liu Y, Liu X. Expressions and clinical significance of serum bone Gla–protein, bone alkaline phosphatase and C-terminal telopeptide of type I collagen in bone metabolism of patients with osteoporosis. Pakistan Journal of Medical Sciences 2015;31:91–94.
   PubMed Web of Science ®Google Scholar
• Ivaska KK, Kakonen SM, Gerdhem P, Obrant KJ, Pettersson K, Vaananen HK. Urinary osteocalcin as a marker of bone metabolism. Clinical Chemistry 2005;51:618–628.
   PubMed Web of Science ®Google Scholar
• Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine & Growth Factor Reviews 2004;15:49–60.
   PubMed Web of Science ®Google Scholar
• Serpooshan V, Sivanesan S, Huang X, Mahmoudi M, Malkovskiy AV, Zhao M, Inayathullah M, Wagh D, Zhang XJ, Metzler S, et al.[Pyr1]-Apelin-13 delivery via nano-iposomal encapsulation attenuates pressure overload-induced cardiac dysfunction. Biomaterials 2015;37:289–298.
   PubMed Web of Science ®Google Scholar
• Kochetkova EA, Volkova MV, Surovenko TN, Gel’tser BI. [Cytokine status in patients with chronic obstructive pulmonary diseases and its relationship with bone tissue functional state]. Terapevticheskii Arkhiv 2004;76:23–27.
   PubMed Web of Science ®Google Scholar
• Scariano JK, Garry PJ, Montoya GD, Chandani AK, Wilson JM, Baumgartner RN. Serum leptin levels, bone mineral density and osteoblast alkaline phosphatase activity in elderly men and women. Mechanisms of Ageing And Development 2003;124:281–286.
   PubMed Web of Science ®Google Scholar
• Hipmair G, Bohler N, Maschek W, Soriguer F, Rojo-Martinez G, Schimetta W, Pichler R. Serum leptin is correlated to high turnover in osteoporosis. Neuro Endocrinology Letters 2010;31:155–160.
   PubMed Web of Science ®Google Scholar
• Ibrahim SE, ElShishtawy HF, Helmy A, Galal ZA, Abdel Salam MH. Serum leptin concentration, bone mineral density and bone biochemical markers in a sample of Egyptian women: a possible relationship. The Egyptian Rheumatologist 2011;33:171–177.
   Google Scholar
• Pobeha P, Ukropec J, Skyba P, Ukropcova B, Joppa P, Kurdiova T, Javorsky M, Klimes I, Tkac I, Gasperikova D, Tkacova R et al. Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. Bone 2011;48:1008–1014.
   PubMed Web of Science ®Google Scholar
• Fraenkel L, Gulanski B, Wittink D. Patient treatment preferences for osteoporosis. Arthritis and Rheumatism 2006;55:729–735.
   PubMed Web of Science ®Google Scholar
• Dontas IA, Yiannakopoulos CK. Risk factors and prevention of osteoporosis-related fractures. Journal of Musculoskeletal & Neuronal Interactions 2007;7:268–272.
   PubMedGoogle Scholar
• Dicou E, AttoubS, Gressens P. Neuroprotective effects of leptin in vivo and in vitro. Neuroreport 2001;12:3947–3951.
   PubMed Web of Science ®Google Scholar